TENKASI subst sèche 1200 mg flac 3 pce

7680681350026 CH-68135 J01XA05 08.01.9.

Active substances:

TENKASI subst sèche 1200 mg flac 3 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6813502
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio sicca: oritavancinum 1200 mg ut oritavancini diphosphas, hydroxypropylbetadexum 2400 mg, mannitolum, acidum phosphoricum q.s. ad pH, natrii hydroxidum q.s. ad pH, pro vitro.

Articles (1)

Tenkasi 1200 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
oritavancinum
1200.0 MG Substance Wirkstoff (Principe actif)
oritavancini diphosphas
- Substance WIZUS
hydroxypropylbetadexum
2400.0 MG Substance HBESI
mannitolum
- Substance HNIDK
acidum phosphoricum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 2260.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2025

Authorization holder

A. Menarini GmbH

8050 Zürich

Authorization information

Swissmedic authorization number
68135
Drug name
Tenkasi, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
J01XA05
Authorization status
Z
Dispensation category
A
First authorization
07/04/2022
Authorization expiration date
06/04/2027
IT number
08.01.9.
Domain
Human medicine
Field of application
Infektionskrankheiten

Packaging details

Description (FR)
TENKASI subst sèche 1200 mg flac 3 pce
Description (DE)
TENKASI Trockensub 1200 mg 1 Durchstf
Market launch
01/06/2025
Narcotic (BTM)
No

Other packaging sizes

TENKASI subst sèche 400 mg flac 3 pce
3 DUR
View
Buy us a coffee Explore the data